Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2017

View Archived Issues

Servier and CTI BioPharma expand Pixuvri agreement

Novel model reveals role of SPP2 gene polymorphism in hypertension

European Commission grants full approval for Tagrisso

Fresenius Kabi to acquire Akorn and Merck KGaA's biosimilars business

ObsEva initiates phase III program for OBE-2109 to treat uterine fibroids

EMA grants PRIME designation to AMT-060 in hemophilia B

Aquinnah Pharmaceuticals receives investment from Pfizer and AbbVie

FDA awards fast track designation to tazemetostat for relapsed or refractory follicular lymphoma

AbbVie seeks Japanese approval for Humira in pustular psoriasis

European Commission grants conditional marketing authorization for Natpar

Endocyte develops small molecule drug conjugate targeting the folate receptor

Akebia and Otsuka expand vadadustat collaboration

FDA approves once-monthly Praluent

Kyowa Hakko Kirin initiates global phase III trial of brodalumab in axial spondyloarthritis

Tessa Therapeutics and Vyriad collaborate to create next generation of cancer immunotherapies

GlaxoSmithKline identifies clinical candidate integrin alphavbeta6 inhibitor

Filgotinib begins new phase II trial in cutaneous lupus erythematosus

Servier and Vernalis announce milestones under oncology drug discovery collaboration

Servier, Vernalis divulge novel dual DYRK1/CLK1 inhibitors

Domain Therapeutics and Pfizer enter collaboration to profile signaling of mutant GPCRs

University of Aberdeen/U.S. Dept. HHS patent thalidomide analogues

Bayer identifies novel CDK9 inhibitors

Almirall discloses new TRPA1 antagonists

Janssen discovers PI3Kbeta inhibitors

SciStar trial of AST-OPC1 for cervical spinal cord injury recommended to continue

Promising preclinical results seen with novel selective CSF-1R inhibitor

Lantheus and GE Healthcare sign definitive license agreement for flurpiridaz F-18

ASLAN initiates pivotal study of varlitinib for biliary tract cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...